Bristol-Myers Squibb Gets FDA Approval for Hodgkin’s Lymphoma Treatment.
Share this article
Regulation
Score 44
Bullish
Bristol-Myers Squibb Gets FDA Approval for Hodgkin’s Lymphoma Treatment
Mar 30, 2026 06:07 UTC
BMY
Medium term
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.